InMed Pharmaceuticals Inc. (INM)

InMed Pharmaceuticals Revenue

InMed Pharmaceuticals had revenue of $1.26M in the quarter ending March 31, 2025, with 7.59% growth. This brings the company's revenue in the last twelve months to $4.92M, down -12.53% year-over-year. In the fiscal year ending June 30, 2024, InMed Pharmaceuticals had annual revenue of $4.60M with 11.18% growth.

• Revenue (ttm): $4.92M
• Revenue Growth: -12.53%
• P/S Ratio: 0.37
• Revenue / Employee: $378,538
• Employees: 13
• Market Cap: 4.08M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	4.60M	462.17K	11.18%
Jun 30, 2023	4.14M	3.05M	279.61%
Jun 30, 2022	1.09M	-	-
Jun 30, 2021	-	-	-
Jun 30, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.